Skip to main content
. 2019 Jan 28;2019(1):CD008940. doi: 10.1002/14651858.CD008940.pub3

Summary of findings 2. Selective serotonin reuptake inhibitor antidepressant compared to placebo for cannabis dependence.

SSRI antidepressant compared to placebo for cannabis dependence
Patient or population: cannabis dependence
 Setting: outpatient
 Intervention: SSRI antidepressant
 Comparison: placebo
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) № of participants
 (studies) Certainty of the evidence
 (GRADE)
Risk with placebo Risk with SSRI antidepressant
Participants abstinent at end of treatment Study population RR 1.73
(0.61 to 4.89)
128
 (2 RCTs) ⊕⊕⊝⊝
 Lowa,b
82 per 1000 142 per 1000
 (50 to 401)
Participants experiencing adverse effects Study population RR 0.76
(0.57 to 1.02)
76
 (1 RCT) ⊕⊝⊝⊝
 Very lowa,c
800 per 1000 608 per 1000
 (456 to 816)
Participants withdrawn due to adverse effects Study population RR 1.71
(0.16 to 18.04)
76
 (1 RCT) ⊕⊝⊝⊝
 Very lowa,c
29 per 1000 49 per 1000
 (5 to 515)
Completion of scheduled treatment Study population RR 0.79
(0.49 to 1.27)
198
 (3 RCTs) ⊕⊝⊝⊝
 Very lowa,b,d
680 per 1000 538 per 1000
 (333 to 864)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio; SSRI: selective serotonin reuptake inhibitor.
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
 Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
 Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
 Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

aDowngraded one level for risk of bias: one study at high risk of bias due to differences in appointment attendance, one study at high risk of attrition bias.

bDowngraded one level for imprecision: very few events and small group sizes.

cDowngraded two levels for imprecision: very few events and small group sizes.

dDowngraded one level for inconsistency: significant heterogeneity between studies.